Boeing Stock Falls Again Ahead of Trump and Xi Talks and a Possible Big China Order
Boeing stock remains under pressure as traders predict a huge Chinese order when Trump-Xi meet in Washington this week
Stocks · News reference
Top Four Catalysts for the S&P 500 and Dow Jones This Week
Here are the top four catalysts for the S&P 500 and Dow Jones indices this week, including the upcoming XI-Trump meeting.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Trump Says Son Donald Trump Jr. ‘Paid’ Russian Boxing Chief Umar Kremlev Over Bahamas Wedding Gift
Trump confirms son Don Jr. repaid Russian boxing chief Umar Kremlev for lavish Bahamas wedding gifts amid ethics scrutiny.
NASA Just Gave SpaceX Another $946 Million Boost, Adding 3 More Crew Dragon Missions to the ISS Through 2030
NASA awarded SpaceX three additional crewed Dragon missions, extending its ISS transportation contract through 2030 for $946 million.
Costco Stock Nears Bear Market: Can Earnings Turn It Around?
Costco stock has dropped and is nearing the bear market zone as investors remain optimistic that the upcoming earnings will turn it around
Better Buy for Cautious Investors: Eli Lilly vs Costco
The article compares Eli Lilly and Costco as defensive stock picks for cautious investors amid market hesitation. Eli Lilly benefits from its dominant GLP-1 weight loss drug portfolio (Mounjaro and Zepbound), while Costco offers stability through its membership-based business model with high renewal rates. Despite both stocks being reasonably valued, the author recommends Costco as the better buy, trading at approximately 39x forward earnings compared to Eli Lilly's historical valuation levels.
Top Wall Street Forecasters Revamp Costco Expectations Ahead Of Q4 Earnings
Costco will report Q4 earnings Sept. 24, with analysts expecting $6.53 EPS and $94.89B revenue; analysts maintain bullish ratings and targets.